St. George's Vascular Institute, London, UK.
J Vasc Surg. 2011 Aug;54(2):353-7. doi: 10.1016/j.jvs.2011.01.029. Epub 2011 Mar 31.
Endovascular aneurysm repair (EVAR) has reduced early adverse outcomes from abdominal aortic aneurysm (AAA) repair. Preferential use of EVAR may have altered the profile of patients who undergo open repair. The validity of scoring systems such as the Glasgow Aneurysm Score (GAS), devised when open surgery was the only treatment, required reappraisal.
Patients were identified from a database of patients undergoing elective infrarenal aneurysm repair at seven United Kingdom centers, and the GAS was calculated for each patient. Discrimination and calibration were calculated to determine the performance of the model in this setting using the C statistic, tertile analysis, and the χ(2) test. Univariate analysis was performed to determine if a new iteration of the GAS could be produced.
We identified 330 patients who met the inclusion criteria. There were 18 deaths ≤30 days of surgery (5.4%). The average (standard deviation) GAS was 78.6 (8.8) for the survivors and 81.9 (10.4) for nonsurvivors (P = .122). The C statistic was 0.625 (95% confidence interval, 0.481-0.769; P = .75) suggesting a discriminatory ability not much better than chance alone. Despite this, calibration of the model was good. There was no significant difference in the comorbidities of either group, so no recalibration of the GAS could be performed.
The GAS did not discriminate between survivors and nonsurvivors after open AAA repair in this cohort. In the era of EVAR, it is possible that the GAS does not predict the outcome of open AAA repair. An alternative explanation is that patients with risk factors for poor outcomes from EVAR, such as adverse AAA morphology, are being selected out for open repair.
血管内动脉瘤修复术(EVAR)降低了腹主动脉瘤(AAA)修复的早期不良结果。EVAR 的优先使用可能改变了接受开放修复的患者的特征。当开放手术是唯一的治疗方法时,设计的格拉斯哥动脉瘤评分(GAS)等评分系统的有效性需要重新评估。
从英国七个中心的择期肾下动脉瘤修复患者数据库中确定患者,并为每位患者计算 GAS。使用 C 统计量、三分位数分析和 χ(2)检验计算模型在这种情况下的区分度和校准度,以确定模型的性能。进行单变量分析以确定是否可以产生新的 GAS 迭代。
我们确定了符合纳入标准的 330 名患者。术后 30 天内有 18 例死亡(5.4%)。幸存者的平均(标准差)GAS 为 78.6(8.8),非幸存者为 81.9(10.4)(P =.122)。C 统计量为 0.625(95%置信区间,0.481-0.769;P =.75),表明区分能力并不比单纯机会好多少。尽管如此,该模型的校准还是不错的。两组的合并症没有显著差异,因此无法对 GAS 进行重新校准。
在这组患者中,GAS 不能区分开放 AAA 修复后的幸存者和非幸存者。在 EVAR 时代,GAS 可能无法预测开放 AAA 修复的结果。另一种解释是,EVAR 预后不良的危险因素(如不良的 AAA 形态)的患者被选择接受开放修复。